podophyllotoxin has been researched along with Thrombopenia in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (88.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buset, EM; Haile, SR; Honegger, H; Knuth, A; Mischo, A; Pestalozzi, BC; Petrausch, U; Renner, C; Samaras, P; Schanz, U; Siciliano, RD; Stahel, RA; Stenner-Liewen, F; Stussi, G | 1 |
| Klastersky, J; Longeval, E; Nicaise, C; Stryckmans, P | 1 |
| Deboer, G; Dill, J; Evans, WK; Feld, R; Osoba, D; Shepherd, FA | 1 |
| Araya, Y; Dosaka, H; Isobe, H; Ito, M; Kawakami, Y; Miyamoto, H; Onodera, S; Shimizu, T; Takaoka, K | 1 |
| Carbone, A; Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, M; Tumolo, S; Veronesi, A; Volpe, R | 1 |
| Aisner, J; Konits, PH; Morris, D; Van Echo, DA; Wiernik, PH | 1 |
| Demitrish, M; Duffin, H; Enochs, K; Groshko, G; Lockhard, C; Maniscalco-Greb, E; Vaughn, CB | 1 |
| Barrett, A; Fitzharris, BM; Kaye, SB; McElwain, TJ; Newlands, ES; Peckham, MJ; Saverymuttu, S | 1 |
| Schulz, JJ; Speckhart, VJ; Spremulli, E; Wampler, GL | 1 |
| Cavalli, F; D'Incalci, M; De Fusco, M; de Jong, J; Hanauske, A; Kaeser-Fröhlich, A; Pagani, O; Sessa, C; Zucchetti, M | 1 |
| Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
| Olhagen, B | 1 |
| Boas, J; Dombernowsky, P; Engelholm, SA; Hansen, OP; Rasmussen, D | 1 |
| Bonardi, GM; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
| Greco, FA; Grosh, WW; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN | 1 |
| Fukuoka, M; Hirano, M; Honma, T; Hoshino, A; Meguro, S; Nakamura, T; Ogawa, M; Shirakawa, S; Toki, H; Yoshida, S | 1 |
| Dang, P; Deboer, G; Evans, WK; Feld, R; Osoba, D; Shepherd, FA | 1 |
| Einhorn, LH | 1 |
| Hashimoto, S; Kano, A; Kawamoto, K; Konno, K; Sakata, Y; Sato, S; Takahashi, H; Wakui, A; Yokoyama, M; Yoshida, Y | 1 |
| Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Kohsaki, M; Konishi, I; Masaoka, T; Nagai, K; Shibata, H; Tsubaki, K | 1 |
| Amiel, JL; Céoara, B; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Oldham, R; Pouillart, P; Rosenfeld, C; Schneider, M; Schwarzenberg, L; Steresco-Musset, M; Weiner, R | 1 |
| Amiel, JL; De Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Oldham, R; Pouillart, P; Rosenfeld, C; Schneider, M; Schwarzenberg, L; Weiner, R | 1 |
| Mann-Kaplan, RS; Reynolds, AF; Rosenblum, ML; Sklansky, BD; Walker, MD | 1 |
| Hansen, HH; Muggia, FM; Selawry, OS | 1 |
5 trial(s) available for podophyllotoxin and Thrombopenia
| Article | Year |
|---|---|
Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Middle Aged; Podophyllotoxin; Thrombocytopenia | 1982 |
Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Podophyllotoxin; Thrombocytopenia | 1996 |
Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.
Topics: Adult; Aged; Agranulocytosis; Alopecia; Antineoplastic Agents; Female; Glycosides; Hodgkin Disease; Humans; Lactones; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nausea; Neoplasms; Neutrophils; Podophyllotoxin; Remission, Spontaneous; Thrombocytopenia; Vomiting | 1973 |
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
Topics: Adolescent; Adult; Aged; Alopecia; Child; Child, Preschool; Clinical Trials as Topic; Digestive System; Drug Evaluation; Female; Glycosides; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pleural Effusion; Podophyllotoxin; Thrombocytopenia | 1974 |
Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819).
Topics: Aged; Antineoplastic Agents; Astrocytoma; Clinical Trials as Topic; Esophageal Neoplasms; Evaluation Studies as Topic; Fibroblasts; Glycosides; Humans; Hypotension; Lactones; Leiomyosarcoma; Leukopenia; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Mitosis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Structure-Activity Relationship; Thiophenes; Thrombocytopenia | 1971 |
20 other study(ies) available for podophyllotoxin and Thrombopenia
| Article | Year |
|---|---|
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Polyethylene Glycols; Recombinant Proteins; Severity of Illness Index; Thrombocytopenia; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.
Topics: Adult; Aged; Agranulocytosis; Bone Marrow Transplantation; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukocyte Count; Male; Middle Aged; Pilot Projects; Podophyllotoxin; Thrombocytopenia | 1982 |
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia; Time Factors | 1984 |
[Effects of oral etoposide in small cell carcinoma of the lung].
Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Small Cell; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Nausea; Podophyllotoxin; Thrombocytopenia | 1984 |
A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Topics: Adult; Age Factors; Aged; Asthenia; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1984 |
VP-16 and adriamycin in patients with advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Podophyllotoxin; Prednisone; Thrombocytopenia; Vincristine; Vomiting | 1982 |
VP16-213 as a single agent in advanced testicular tumors.
Topics: Drug Evaluation; Dysgerminoma; Etoposide; Humans; Leukopenia; Male; Podophyllotoxin; Teratoma; Testicular Neoplasms; Thrombocytopenia | 1980 |
Phase II study of VM-26 in adult malignancies.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Teniposide; Thrombocytopenia | 1980 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
[Immunosuppressive treatment of rheumatologic diseases].
Topics: Arthritis; Arthritis, Rheumatoid; Drug Evaluation; Female; Humans; Immunity, Cellular; Immunosuppression Therapy; Male; Penicillamine; Podophyllotoxin; Pregnancy; Rheumatic Diseases; Thrombocytopenia | 1976 |
Phase II study of teniposide in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1990 |
Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1988 |
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Podophyllotoxin; Thrombocytopenia; Vincristine | 1985 |
[Phase II study of VP-16 (capsule) in solid tumors. A cooperative study].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Capsules; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Podophyllotoxin; Soft Tissue Neoplasms; Thrombocytopenia | 1985 |
VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Podophyllotoxin; Thrombocytopenia; Time Factors | 1985 |
VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Nausea; Neoplasm Metastasis; Podophyllotoxin; Testicular Neoplasms; Thrombocytopenia; Vomiting | 1986 |
[A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
Topics: Adult; Aged; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kinetics; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Thrombocytopenia | 1986 |
[Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
Topics: Administration, Oral; Adult; Aged; Capsules; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia | 1985 |
[Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lymphatic Diseases; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia | 1974 |
Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms.
Topics: Adolescent; Adult; Anemia; Astrocytoma; Brain Neoplasms; Carcinoma, Bronchogenic; Child; Ependymoma; Evaluation Studies as Topic; Female; Glioma; Humans; Leukopenia; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Neurologic Examination; Podophyllotoxin; Remission, Spontaneous; Thrombocytopenia | 1974 |